"CGB might be suspended but it would be one of the better...

"CGB might be suspended but it would be one of the better positioned and $ healthiest on the ASX."

As can be seen below, there are multiple subsidaries under the umbrella, all of which obviously attract expenses to keep active, so I'd be quite interested to be educated as to how they are 'one of the better positioned' in the industry.

Insofaras " $ healthiest " is concerned.... how would we know ?
Continuous Disclosure is being ignored by not divulging to the Market/Investors what the current cash position is via Q3 Jan-Mar Report

For the last/previous 2 quarters (well, what we know of up to Dec 2022) the focus on income is down to Grass Roots - Not On Any of the other subsidaries !

Do Grass Roots or Fuss Pot have anything to do with CGB having changed into a "Medical Cannabis" company ?????
They're not even a "Domestic" leader in the MC space, nevermind the bs of being a "Global Leader"
Embarrasingly Laughable would be a more apt description imo for anyone considering a new investment here.

Annual Report for FY 2021/2022 info :- 12 Subsidaries - 1 shut down - 11 active -
Combined income for Q1 2023 (30/09) - $54,000 ("Primarily driven by Grass Roots domestic sales")
Combined income for Q2 2023 (31/12) - $78,000 ("Primarily driven by Grass Roots domestic sales")


Subsidiaries of Cann Global Limited: (FussPot might have been added to this list since this report)

South Johnstone Bauxite Pty Ltd Australia 100%

Volcan Queensland Bauxite Pty Ltd Australia 100%

Medical Cannabis Limited Australia 100%

Medical Cannabis Research Group Pty Ltd Australia 100%

Vitahemp Pty Ltd Australia 95%

Vitaseeds Pty Ltd Australia 100%

Vitacann Pty Ltd Australia 100%

T12 Holdings Pty Ltd Australia 100%

Hemp Hulling Co (QLD) Pty Ltd1 Australia 55% (shut down in March 2022)

Cann Global Asia Pty Ltd Australia 55%

Cann Global Thailand Pty Ltd Australia 55%

Medical Cannabis (Cambodia) Co., Ltd Cambodia 51%